054950 — JVM Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for JVM Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	115,826	141,978	157,085	159,434	173,129
Cost of Revenue
Gross Profit	39,249	51,157	62,595	63,725	70,839
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	104,652	122,002	127,315	128,759	139,853
Operating Profit	11,175	19,975	29,771	30,675	33,276
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	9,404	21,279	33,105	34,692	36,180
Provision for Income Taxes
Net Income After Taxes	8,951	15,756	26,244	28,844	28,351
Net Income Before Extraordinary Items
Net Income	8,951	15,756	26,244	28,844	28,351
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	8,951	15,756	26,244	28,844	28,351
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,065	1,498	2,279	2,551	2,457
Dividends per Share